The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.

Conditions: HER2-positive Breast Cancer Interventions: Diagnostic Test: GeoMx data analysis with clinical outcome Sponsors: Samsung Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials